Cargando…
Joint population pharmacokinetic modeling of venlafaxine and O-desmethyl venlafaxine in healthy volunteers and patients to evaluate the impact of morbidity and concomitant medication
Introduction: Venlafaxine (VEN) is a widely used dual selective serotonin/noradrenaline reuptake inhibitor indicated for depression and anxiety. It undergoes first-pass metabolism to its active metabolite, O-desmethyl venlafaxine (ODV). The aim of the present study was to develop a joint population...
Autores principales: | Wang, Zhanzhang, Li, Lu, Huang, Shanqing, Wang, Xipei, Liu, Shujing, Li, Xiaolin, Kong, Wan, Ni, Xiaojia, Zhang, Ming, Huang, Shanshan, Tan, Yaqian, Wen, Yuguan, Shang, Dewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772442/ https://www.ncbi.nlm.nih.gov/pubmed/36569310 http://dx.doi.org/10.3389/fphar.2022.978202 |
Ejemplares similares
-
Multiple-reaction monitoring (MRM) LC–MS/MS quantitation of venlafaxine and its O-desmethyl metabolite for a preclinical pharmacokinetic study in rabbits
por: Fazli, Abdul Aala, et al.
Publicado: (2022) -
VENLAFAXINE-INDUCED MANIA
por: Jagadheesan, K., et al.
Publicado: (2001) -
Venlafaxine besylate monohydrate
por: Corvalan, Carolina H., et al.
Publicado: (2013) -
Kleptomania Induced by Venlafaxine
por: Sakurada, Kumi, et al.
Publicado: (2021) -
Venlafaxine-induced hypoglycemia
por: Kobylianskii, Jane, et al.
Publicado: (2021)